Pinned straw:
@Strawman thanks for picking out the key points. I've set aside time later today to watch both presentations and look at the numbers myself.
Here are further initial musings.
It is clear they these guys are massive multi-taskers, with no-one in the organisation tasked with doing QA/QC on external disclosures. (Points to a weak or over-stretched CFO, IMHO, as that's the role the MD/CEO and Board rely on to make sure all numbers are tight.) Very odd behaviour not to give the guidance update yesterday, and then to do a market sensistive announcement for a Share Cafe presentation that then gives the guidance. At least this time they flagged it as market senstive and released it before the start of the presentation.
I assume all the numbers presented exlcude transaction costs, which I expect to be in the range $0.3-$0.5m.
Secondly, I agree with the comment you and others have made about revenue growth. How credible are FY25 and FY28 targets, given the modest FY23 to FY24 movement? Surely, they are going to rely on more M&A to hit the targets? Or do they see the prospect of strong revenue synergies from the combination?
Now there is nothing wrong with acquiring scale, as long as they get good prices and pick up quality assets that are easy to integrate, while not taking on too much debt. So far, it appears, OK.
With Force valued at EV/EBITDA of 4, if $SGI is trading on an EV/EBITDA of about 8.4 at FY23, and probably around 9+ at the moment before the addition of Force, and with Force having a higher EBITDA Margin (2.5/44 or 6%, which is better than %SGI at 3%'ish), then Force is a better quality business and it shouldn't dilute the $SGI ratios ---- classic roll-up mechanics).
On revenue synergies, I can see how part of the Force product portfolio will cross-sell nicely into the Stealth Business & Trade customers, and how the Stealth product portfolio will cross sell nicely into the Force Business and Trade customer base. Not clear how much of the Stealth portfolio will sell into the Retailer and Retail Resellers. However, overall, its seems reasonable that they will get "1+1>2" on the revenue side over time, strenthening organic growth in the next 1-2 years. How much? No idea. But it could be a nice little kicker if revenue growth in the underlying business is only 2-5%.
I am curious to see that the revenue growth of 2-5% has flowed through to +25% on EBITDA, NPBT and NPAT, although I recall that EBITDA margins on incremental sales are 15% (1HFY24/1HFY23) ... the maths will be easy enough to check.
So, overall, I think the deal stacks up. Ultimately, it will be good to see proper audited numbers at the FY, and then track progress through FY25. Hopefully, $SGI will report the contribution of each of the businesses separately, both proforma for full year, and the contribution to the FY24 result.
On first inspection, I feel happy enough to continue to ride this bus, but will have a look at the P/E of the combination.